NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
Home/BCI for Paralysis
CLINICAL APPLICATION // PARALYSIS & MOVEMENT RESTORATION

Brain Implants for Paralysis: How BCI Is Restoring Movement

As of March 2026, brain-computer interfaces are restoring communication and movement for people with paralysis across four major clinical platforms. Neuralink has implanted 21 patients with its 1,024-electrode N1 chip, enabling cursor control, gaming, and computer operation through thought alone. Synchron has implanted 10 patients using a minimally invasive blood vessel approach, with patients browsing the web and controlling Apple Vision Pro. BrainGate pioneered the field with 15+ patients over two decades, including the first person to control a robotic arm with thoughts. Onward Medical has demonstrated that spinal stimulation can restore voluntary leg movement and standing in 50+ patients with complete spinal cord injury. The field is moving from proof-of-concept to scalable clinical deployment.

208247+ Patients Implanted
4 Major Platforms
19+ Active Trials
6+ Countries
Last updated: March 2026 · View all clinical trials →

BCI PLATFORMS FOR PARALYSIS

NeuralinkN1 Implant (Telepathy)
21 patientsRecruiting
Intracortical (1,024 electrodes) · Quadriplegia, ALS · PRIME Feasibility Study

First patient achieved 8+ bits/sec cursor control, 62 WPM typing, plays video games. ALS patient narrated and edited a YouTube video.

SynchronStentrode
10 patientsRecruiting (COMMAND)
Endovascular (16 electrodes) · ALS, severe paralysis · SWITCH + COMMAND

Patients browsing web, sending messages, controlling Apple Vision Pro. Zero serious brain/vascular adverse events.

BrainGateUtah Array (BlackRock)
15+ patientsActive
Intracortical (96 electrodes) · Quadriplegia, locked-in syndrome · BrainGate2 (NCT00912041)

First patient to control a robotic arm to drink coffee. Demonstrated typing, cursor control, and neural speech decoding.

Onward MedicalARC-IM / ARC-EX
50+ patientsRecruiting
Epidural spinal stimulation · Spinal cord injury · Up-LIFT, STIMO-2

Restored voluntary leg movement, standing, and walking in complete SCI patients. Bladder and blood pressure control improvements.

PLATFORM COMPARISON

PLATFORMAPPROACHELECTRODESSURGERYPATIENTSBEST FOR
Neuralink N1Intracortical1,024Craniotomy (robot-assisted)21High-bandwidth cursor/device control
Synchron StentrodeEndovascular16Catheter (no brain surgery)10Low-risk digital access (web, messaging)
BrainGate Utah ArrayIntracortical96Craniotomy (manual)15+Robotic arm control, research
Onward ARC-IMEpidural spinal16Spinal surgery50+Leg movement, standing, walking

BOTTOM LINE

Brain-computer interfaces for paralysis have moved from laboratory curiosity to clinical reality. Neuralink leads on bandwidth and capability — its 1,024-electrode N1 implant enables the highest-resolution brain signal recording ever achieved in humans, and patients are using it for hours daily for practical tasks. Synchron leads on surgical accessibility — no brain surgery required, making it deployable by any interventional neurologist. BrainGate pioneered the field and continues to push the frontier of robotic arm control. Onward Medical addresses the largest patient population — the 300,000+ people worldwide with spinal cord injury — through spinal stimulation that can restore actual leg movement. The next 2-3 years will be decisive: Neuralink plans high-volume automated surgery, Synchron is preparing its pivotal trial, and Onward is seeking European regulatory approval. The question is no longer whether BCIs work for paralysis — it is how fast they can scale.

FREQUENTLY ASKED QUESTIONS

RELATED INTELLIGENCE

Neuralink vs Synchron: Complete BCI ComparisonInvasive vs Non-Invasive BCI ExplainedBCI FDA Approval Tracker